Nu Skin Enterprises, Inc.
NYSE:NUSHousehold & Personal Products
+$0.13 today
- Market cap
- $188.38M
- Beta
- 0.95
- P/E (TTM)
- 4.5
- EPS (TTM)
- $1.13
- Dividend yield
- 4.70%
Volume 0.59M
Average 0.57M
NUS Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Nu Skin Enterprises, Inc.NYSE: NUS
Deferred Revenue · Q1 FY2026 · quarter ended Mar 2026
Deferred revenue remains negative
Q1 FY2026 deferred revenue was $6.2M, compared with $0 a year earlier.
Context
- Deferred revenue amounted to 0.5% of total assets at the end of Q1 FY2026, up 0.5 pp from a year earlier.
- Deferred revenue increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 15.69M | -23.1% |
| FY2023 | 2023-12-31 | 20.39M | -24.6% |
| FY2022 | 2022-12-31 | 27.05M | -18.4% |
| FY2021 | 2021-12-31 | 33.14M | — |
Deferred Revenue vs competitors
How NUS compares with its peers on the latest reported figures
- NUS's Mar 2026 deferred revenue of $6.2M is the 3rd highest of the 8 companies compared; the peer median is $0.
- Deferred revenue amounts to 0.5% of total assets for NUS, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $39.29M | +36.2% | +22.3% | 8.1% | |
| Mar 2026 | $25.19M | +0.4% | -1.1% | 4.7% | |
| Mar 2026 | $6.2M | — | — | 0.5% | |
| Feb 2026 | $0 | — | — | 0.0% | |
| Apr 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding NUS) | $0 | +18.3% | +10.6% | 0.0% | |
Competitors are the stored peer set for NUS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 339.59M | 264.73M | 256.06M | 186.88M | 238.63M |
| Short-term Investments | 15.22M | 13.78M | 11.76M | 11.11M | 1.21M |
| Net Receivables | 41.3M | 47.36M | 72.88M | 50.78M | 39.54M |
| Inventory | 399.93M | 346.18M | 279.98M | 190.24M | 178.64M |
| Other Current Assets | 32.43M | 39.33M | 37.1M | 51.39M | 89.67M |
| Total Current Assets | 872.95M | 759.87M | 701.87M | 538.6M | 547.7M |
| Property, Plant & Equipment (Net) | 598.25M | 571.67M | 523.07M | 466.91M | 451.19M |
| Goodwill | 206.43M | 206.43M | 230.77M | 83.63M | 83.63M |
| Intangible Assets | 76.99M | 66.7M | 105.31M | 74.28M | 42.61M |
| Long-term Investments | 35.87M | 39.49M | 40.11M | 39.59M | 18.75M |
| Tax Assets | 26.48M | 89.77M | 105.53M | 174.25M | 0 |
| Other Non-current Assets | 89.51M | 87.04M | 99.81M | 91.67M | 261.44M |
| Total Non-current Assets | 1.03B | 1.06B | 1.1B | 930.32M | 857.62M |
| Total Assets | 1.91B | 1.82B | 1.81B | 1.47B | 1.41B |
| Account Payables | 49.99M | 53.96M | 43.11M | 34.88M | 26.18M |
| Short-term Debt | 107.5M | 25M | 25M | 30M | 20M |
| Tax Payables | 31.14M | 21.82M | 21.25M | 22.14M | 0 |
| Deferred Revenue | 33.14M | 27.05M | 20.39M | 15.69M | 0 |
| Other Current Liabilities | 3.51M | 3.36M | 68.79M | 23.89M | 191.76M |
| Total Current Liabilities | 529.69M | 359.24M | 328.87M | 296.61M | 263.73M |
| Long-term Debt | 268.78M | 377.47M | 478.04M | 363.61M | 261.83M |
| Deferred Tax Liabilities | 24.16M | 35.97M | 522K | 39.87M | 310K |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 77M | 62.31M | 96.67M | 50.68M | 10.22M |
| Total Non-current Liabilities | 464.01M | 564.43M | 655.62M | 520.85M | 336.34M |
| Total Liabilities | 993.71M | 923.67M | 984.5M | 817.46M | 600.07M |
| Common Stock | 91K | 91K | 91K | 91K | 91K |
| Retained Earnings | 1.91B | 1.94B | 1.87B | 1.71B | 1.86B |
| Accumulated OCI | (73.9M) | (86.51M) | (100.01M) | (124.76M) | (116.11M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 912.77M | 897.3M | 821.97M | 651.46M | 805.24M |
| Total Debt | 503.79M | 520.52M | 607.33M | 478.23M | 364.25M |
| Net Debt | 164.19M | 255.8M | 351.27M | 291.34M | 125.62M |
Nu Skin Enterprises, Inc.
NYSE:NUS
Intrinsic Alpha fair value
Locked
Current Price
$3.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.